Clinical Trial Update: Low Dose Naltrexone for Pain in Patients With HIV [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating low-dose naltrexone for pain in people with HIV is currently recruiting, sponsored by Emory University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Neuropathic Pain

Drugs mentioned

• Naltrexone (Naltrexone)

Snippet

Sponsor: Emory University | Conditions: Human Immunodeficiency Virus, Chronic Neuropathic Pain | Phase 4 | Status: RECRUITING